摘要
目的:研究高血压病患者过氧化物酶体增殖物激活受体(PPAR)γ2基因Pro12Ala多态性与血糖水平之间的关系。方法:纳入177名原发性高血压患者,其中空腹血糖(FBG)<5.6 mmol/L组65例,FBG≥5.6 mmol/L组112例,收集一般资料;分别测定空腹及餐后2小时血糖、胰岛素;对PPARγ2基因Pro12Ala多态性与各临床变量的关系进行研究。结果:FBG<5.6 mmol/L组和FBG≥5.6 mmol/L组Pro和Ala等位基因频率分别为0.333,0.034及0.602,0.031;PP和PA基因型频率分别为0.299,0.068及0.571,0.062;无AA型纯合子。以体重指数(BMI)分层后,BMI<25组内,FBG与PPARγ2基因型相关(P=0.029)。以基因型分组比较,PA组空腹血糖水平和胰岛素抵抗指数都低于PP组(P<0.05)。结论:成都地区高血压患者PPARγ2基因Pro12Ala多态性与空腹血糖水平相关,且携带Ala基因者空腹血糖水平较低,胰岛素抵抗较轻,推测该突变可能有减轻高血压病患者胰岛素抵抗,改善糖代谢异常的作用。
Objective：To study the association between the Pro12Ala polymorphism in peroxisome proliferators-activated receptor-γ2（PPARγ2 ） gene and blood glucose levels in patients with primary hypertension.Methods：The Pro12Ala polymorphism in PPARγ2 was determined by polymerase chain reaction-restriction fragment length polymorphism （PCR-RELP） in 177 subjects with primary hypertension of the Han people in Chengdu of China,including 65 subjects with fasting blood glucose（FBG）5.6 mmol/L and 112 subjects with FBG≥5.6 mmol/L;the clinical characteristics including height,weight,OGTT（0h and 2h） of the subjects were detected and the realationship between the Pro12Ala polymorphism and the clinical characteristics were analysed.Results：The allele frequencies in the group with FBG5.6 mmol/L and FBG≥5.6 mmol/L were 0.333,0.602 for Pro and 0.034,0.031 for Ala.The genotype frequencies were 0.299,0.571 for PP and 0.068,0.062 for PA,and there was no AA.In the group with BMI25,the Pro12Ala polymorphism was associated with FBG（P=0.029）.the Ala allele had a negative relationship to the FPG and insulin resistance index（IRI）（P0.05）.Conclusion：The data showed that the Pro12Ala polymorphism was associated with FBG.,and The allele Ala probably had benefits to glycometabolic disturbance in patients with primary hypertension by declining insulin resistance.
出处
《华西医学》
CAS
2009年第11期2820-2823,共4页
West China Medical Journal
